Diabetes
Rybelsus
Semaglutide
Semaglutide
Generally used in combination with exercise and diet regimens, Semaglutide, also known as Rybelsus, helps ...
Glucophage
Metformin
Metformin
Glucophage é um medicamento diabetico oral utilizado no tratamento da diabetes tipo 2.
Actos
Pioglitazone
Pioglitazone
Actos (Pioglitazone) is used to control high blood sugar in type 2 diabetes (non-insulin-dependent diabetes ...
Glucophage SR
Metformin
Metformin
Glucophage SR is an oral diabetes medicine used to treat type 2 of diabetes.
Prandin
Repaglinide
Repaglinide
Prandin is used to stimulate insulin secretion from the pancreas in treatment of type 2 of diabetes mellitus.
Amaryl
Glimepiride
Glimepiride
Amaryl is an oral blood sugar-lowering drug which belongs to the class of sulfonylureas.
Glucotrol Xl
Glipizide
Glipizide
Glucotrol Xl is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
Glucovance
Metformin/Glyburide
Metformin/Glyburide
Glucovance is a combination of two orally taken drugs possessing a hyproglycemic effect. Used to treat ...
Formas De Pagamento:
Processo De Pagamento Seguro:




Notícias
Supported housing in crisis, groups tell Starmer
Supported housing for vulnerable or disabled people is in crisis, a letter to the prime minister says.
'My peanut allergy nearly killed me - now I eat them every day for breakfast'
Just a few years ago, Chris Brookes-Smith could have died from eating peanuts - but taking part in a clinical trial has changed his life.
Exhausted hospital staff putting patients at risk, says watchdog
NHS safety body wants a focus on staff fatigue as it warns of mistakes and impaired decision-making.
Notícias
Covid-19: Oxford University vaccine shows 70% protection
Other groups have reported higher protection, but the results are still seen as a triumph.
Covid risk: 3 people, 3 very different Covid risks. What's yours?
A question everyone's asking: what's my Covid risk? Here's how to find out.
Coronavirus: £3bn for NHS but Sunak warns of 'economic shock' to come
Borrowing - which hit a record £22.3bn in October - cannot go on indefinitely, chancellor says.